previous arrow
next arrow

Who we are

UPMC Hillman Cancer Center at Villa Maria
UPMC Hillman Cancer Center at Villa Maria is an advanced radiotherapy center offering treatments for primary tumors, secondary (metastatic) or recurrent tumors in all parts of the body. Stereotactic radiotherapy is a valid alternative to invasive surgery for all tumors surgically difficult to reach, and for patients with specific contraindications to surgery. The most advanced linear accelerator on the market today, TrueBeam® STx, is available at the Center and can deliver high doses of radiation more quickly and more precisely, allowing for shorter treatments with minimal side effects.
UPMC Hillman Cancer Center at Villa Maria was created in 2018 in Mirabella Eclano (near Avellino) from a collaboration between UPMC Italy and Casa di Cura Villa Maria, a 92-bed private hospital (40 beds are accredited with the Italian National Health System) with four departments: general surgery, urology, orthopedics, and ophthalmology. The underlying goal of the partnership is to create an oncology center in center-southern Italy providing high quality care to patients in that area.

UPMC Hillman Cancer Center
UPMC Hillman Cancer Center network (60 locations in the U.S. and Europe) ensures highest standards of care to over 113,000 patients every year. The UPMC oncology network is affiliated with the University of Pittsburgh. Together, the organizations have published over 5,700 research studies in the last five years and were granted research funds of more than $111 million in 2018. Being part of this network allows every center of the UPMC network, including UPMC Hillman Cancer Center Villa Maria, to be involved in research initiatives that ensure the ongoing development of treatment techniques. In addition, thanks to state-of-the-art telemedicine systems, our specialists can share daily experience and clinical cases with their colleagues in Europe and in the United States. This model of communication and collaboration allows our Center to rely on the experience of one of the most extensive stereotactic surgery programs in the world, whilst guaranteeing patients the best results and the quality and safety standards of UPMC cancer centers. UPMC’s cancer program is consistently placed on the U.S. News & World Reports “Best of Best” cancer programs in the United States.

UPMC Italy
UPMC Italy is the Italian division of the UPMC (University of Pittsburgh Medical Center). UPMC Italy operates in the field of patient care, biomedical research, telemedicine, training, construction planning, IT solutions, and provides support to areas directly and indirectly related to hospitals and research institutions. In addition to UPMC Hillman Cancer Center Villa Maria, UPMC Italy manages centers in Palermo and Rome.

Since 1997, UPMC Italy has been managing IRCCS ISMETT, a government-approved research hospital and a center for organ transplants and highly specialized therapies. The Center hosts 114 inpatients beds and 8 Day Hospital beds, plus 4 operating rooms. Since the very first liver transplant performed in Sicily in 1999, over 2,000 transplants have been performed at IRCCS ISMETT.

In partnership with the Italian government, the Sicilian regional government, the Italian National Research Council (CNR), and the University of Pittsburgh, UPMC is a founding member of the Ri.MED Foundation. The Foundation, based in Carini (near Palermo), promotes, supports, and leads biomedical and biotechnological research projects, with an emphasis on translating innovative results to the clinical practice. Ri.MED’s main current project is the creation of the Biomedical Research and Biotechnology Center (BRBC), a 25,000-square meter building that will become a reference point for researchers from all over the world.

In collaboration with San Pietro Fatebenefratelli Hospital, in 2013 UPMC Italy created UPMC Hillman Cancer  Center at San Pietro FBF. The Center offers innovative radiotherapy treatments and stereotactic radiosurgery with oncology protocols for advanced care. In 2017, the Center received accreditation from Joint Commission International (JCI) after an extensive review of its safety and quality standards and processes.

In Rome, UPMC also manages UPMC Salvator Mundi International Hospital, a private hospital offering a wide range of services (internal medicine, general surgery, imaging, rehab and physiotherapy, oncology, etc.) and an integrated oncology center, part of the UPMC Hillman Cancer Center network, for diagnosis and treatment of oncology diseases.

UPMC (University of Pittsburgh Medical Center) is a $19 billion world-renowned health care provider and insurer inventing new models of accountable, cost-effective, patient-centered care. The largest nongovernmental employer in Pennsylvania, UPMC integrates 90,000 employees, more than 40 hospitals, 700 doctors’ offices and outpatient sites. As UPMC works in close collaboration with the University of Pittsburgh Schools of the Health Sciences, U.S. News & World Report consistently ranks UPMC Presbyterian Shadyside on its annual Honor Roll of America’s Best Hospitals.